On October 18, 2019 SFA Therapeutics, Inc. reported that their CEO, Dr. Ira Spector, will update the company’s clinical development plans for several new therapeutic agents they have derived from the human microbiome (Press release, SFA Therapeutics, OCT 18, 2019, View Source [SID1234542363]). The presentation will be delivered as part of the prestigious Bio Investors Forum on October 23rd at 9:45AM in the Elizabethan Room of the Westin St. Francis Hotel in San Francisco, CA.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!